Rx-to-OTC Switch

CHPA Submits Comments on FDA Proposed Rule for Nonprescription Drug Product With an Additional Condition for Nonprescription Use

The Consumer Healthcare Products Association (CHPA) applauds the U.S. Food and Drug Administration’s (FDA) final rule establishing a regulatory category for over-the-counter (OTC) hearing aids which will officially take effect Monday.

CHPA President and CEO, Scott Melville, today released the following statement in response to the U.S. Food and Drug Administration’s announcement of a joint meeting between its Advisory Committees on Nonprescription Drugs and Obstetrics and Reproductive and Urologic Drugs.

When it comes to self-care solutions, pharmacists can be an overlooked resource. Today we speak with Dr. Wendy Mobley-Bukstein, Associate Professor of Pharmacy Practice at Drake University about how pharmacists are playing bigger and critical roles in the self-care ecosystem.

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

CHPA’s President and CEO, Scott Melville, today released a statement in response to news of HRA Pharma’s application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the United States.

Industry executives from Europe and beyond gathered June 7-8, in Madrid, Spain, for the annual meeting of the Association of the European Self-Care Industry (AESGP), its first annual meeting since 2019. Under the theme “supporting innovation in self-care during times of uncertainty,” speakers focused on the European context of environmental sustainability, trends shaping the future of the consumer healthcare business, and the outlook for changes to the EU’s pharmaceutical framework, among other topics.